Fmr LLC Omega Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 6,242,016 shares of OMGA stock, worth $8.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,242,016

Previous 6,293,157 0.81%

Holding current value

$8.86 Million

Previous $23 Million 43.75%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.86 - $3.2 $95,122 - $163,651	-51,141 Reduced 0.81%	6,242,016 $12.9 Million
Q1 2024 May 13, 2024	BUY	$2.73 - $5.32 $2.75 Million - $5.36 Million	1,006,582 Added 19.04%	6,293,157 $23 Million
Q4 2023 Feb 13, 2024	BUY	$1.35 - $3.21 $124,838 - $296,838	92,473 Added 1.78%	5,286,575 $15.9 Million
Q3 2023 Nov 13, 2023	SELL	$2.15 - $5.68 $517,442 - $1.37 Million	-240,671 Reduced 4.43%	5,194,102 $11.2 Million
Q2 2023 Aug 11, 2023	BUY	$5.6 - $9.66 $95,838 - $165,321	17,114 Added 0.32%	5,434,773 $30.4 Million
Q1 2023 May 11, 2023	BUY	$4.81 - $10.95 $3.94 Million - $8.96 Million	818,216 Added 17.79%	5,417,659 $32.7 Million
Q4 2022 Feb 13, 2023	SELL	$4.22 - $7.05 $17,977 - $30,033	-4,260 Reduced 0.09%	4,599,443 $26.3 Million
Q3 2022 Nov 10, 2022	BUY	$3.63 - $6.65 $792,792 - $1.45 Million	218,400 Added 4.98%	4,603,703 $25 Million
Q2 2022 Aug 12, 2022	SELL	$2.01 - $7.19 $549,138 - $1.96 Million	-273,203 Reduced 5.86%	4,385,303 $16.7 Million
Q1 2022 May 13, 2022	BUY	$6.24 - $14.04 $1.43 Million - $3.21 Million	228,825 Added 5.17%	4,658,506 $29.1 Million
Q4 2021 Feb 14, 2022	BUY	$11.33 - $29.38 $2.59 Million - $6.71 Million	228,500 Added 5.44%	4,429,681 $48.9 Million
Q3 2021 Nov 15, 2021	BUY	$16.0 - $22.51 $67.2 Million - $94.6 Million	4,201,181 New	4,201,181 $79.2 Million

Others Institutions Holding OMGA

# of Institutions

Shares Held

45.3M

Call Options Held

36.9K

Put Options Held

33.5K

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $68M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account